Page results
-
This page tells you about having a PICC (Peripherally Inserted Central Catheter) line insertion with the Vascular Access team.
-
Patient information who have been recommended to use a Biatain® dressing on your skin that has broken down due to your radiotherapy or proton beam therapy treatment.
-
A smartphone app that identifies severe neonatal jaundice could provide a cheaper alternative to expensive screening procedures, according to a study by UCLH, UCL and the University of Ghana.
-
This information explains brain stem death and the tests used to confirm the diagnosis. It aims to answer frequently asked questions.
-
Patient Advice and Liaison Service (PALS)
-
Acute Myeloid Leukaemia (AML) is a form of cancer that develops in your bone marrow and affects your blood cells.
-
Your acute myeloid leukaemia (AML) treatment will be delivered within a number of comprehensive specialised services led by medical and nursing cancer care experts.
-
Acute lymphoblastic leukaemia (ALL) is a form of cancer that affects the cells in the bone marrow, the soft material inside your bones.
-
This booklet tells you about having a Vortex® Port-a-cath Insertion (implantable port) with the Interventional Radiology team.
-
Your treatment for acute lymphoblastic leukaemia (ALL) will be delivered within a number of comprehensive specialised services led by medical and nursing cancer care experts.
File results
-
FOI/2024/0697 - Autism spectrum disorder (ASD)/ attention deficit hyperactivity disorder (ADHD) and mental health services
-
FOI/2024/0696 - Various IT systems used at Trust
-
FOI/2024/0695 - Air filtration used/ air exchange rate across Trust
-
FOI/2024/0693 - Patients overhead or ceiling track hoists portable/ mobile hoists installed
-
FOI/2024/0692 - Integrated Care Board (ICB) expenditure sign-off process 2023/24
-
FOI/2024/0691 - Information distributed to pregnant/ post-partum women for infant feeding
-
FOI/2024/0690 - Mechanical transport ventilation/ ventway sparrow transport ventilator
-
FOI/2024/0687 - Newly diagnosed patients with AML starting first line treatment - February-July 2024
-
FOI/2024/0685 - Lunch/ dinner menus for patients
-
FOI/2024/0662 - Treatment of haematology/ Myeloprolifeative diseases/ Non Hodgkin Lymphoma/ Chronic Lymphocytic Leukaemia/ Mantle Cell Lymphoma